Sigyn Therapeutics (SIGY) Return on Assets (2018 - 2025)
Sigyn Therapeutics (SIGY) posted Return on Assets of 0.34% for Q3 2025, down 32.59% sequentially from 0.26% in Q2 2025, and down 24.0% YoY from 0.45% in Q3 2024.
Sigyn Therapeutics (SIGY) Return on Assets (2018 - 2025) Analysis & Trends
Sigyn Therapeutics has reported Return on Assets for 8 years, with the latest figure at 0.34% in Q3 2025.
- Quarterly Return on Assets fell 24.0% year-over-year to 0.34% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 0.34% (down 24.0% YoY) and the FY2024 annual result came in at 0.12%, changed 0.0% from the prior year.
- Return on Assets eased to 0.34% in Q3 2025 per SIGY's latest filing, from 0.26% in the prior quarter.
- Over five years, Return on Assets peaked at 0.01% in Q3 2021 and troughed at 0.34% in Q3 2025.
- A 5-year average of 0.1% and a median of 0.09% in 2022 frame the typical range for Return on Assets.
- The sharpest annual moves came in 2023 and 2025: Return on Assets rose 1 bps in 2023, then fell 24 bps in 2025.
- Over 5 years, Return on Assets stood at 0.03% in 2021, then plunged by 202 bps to 0.08% in 2022, then slumped by 39 bps to 0.12% in 2023, then advanced by 11 bps to 0.1% in 2024, then plunged by 230 bps to 0.34% in 2025.
- According to Business Quant data, Return on Assets over the past three periods registered 0.34%, 0.26%, and 0.14% for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 0.00% |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - | -0.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.34% |
| Jun 30, 2025 | -0.26% |
| Mar 31, 2025 | -0.14% |
| Dec 31, 2024 | -0.10% |
| Sep 30, 2024 | -0.11% |
| Jun 30, 2024 | -0.12% |
| Mar 31, 2024 | -0.11% |
| Dec 31, 2023 | -0.12% |
| Sep 30, 2023 | -0.10% |
| Jun 30, 2023 | -0.07% |
| Mar 31, 2023 | -0.07% |
| Dec 31, 2022 | -0.08% |
| Sep 30, 2022 | -0.09% |
| Jun 30, 2022 | -0.08% |
| Mar 31, 2022 | -0.06% |
| Dec 31, 2021 | -0.03% |
| Sep 30, 2021 | -0.01% |
| Jun 30, 2021 | -0.01% |
| Mar 31, 2021 | -0.02% |
| Dec 31, 2020 | -0.02% |